Health Products

APO-Metformin (2020-02-04)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

APO-Metformin 500 mg Tablet

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
NV3242, NV3244, NV3245, NV3243, NV3247, NV3248, PX5334, PX5335
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
APO-Metformin 500 mg TabletDIN 02305062Tablet (Extended-Release)Metformin Chlorohydrate 500 mg

Reason

Presence of N-nitrosodimethylamine (NDMA) above the interim acceptable concentration limit in affected lot(s).

Depth of distribution

Wholesalers, Healthcare Establishments, Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime